Introduction to Refractory Autoimmune

Sentence Examples

Discover more insights into Refractory Autoimmune

Keywords frequently search together with Refractory Autoimmune

Narrow sentence examples with built-in keyword filters

Refractory Autoimmune sentence examples within hematopoietic stem cell

hematopoietic stem cell

Over the past decades, hematopoietic stem cell transplantation (HSCT) has been evolving as specific treatment for patients with severe and refractory autoimmune diseases (ADs), where mechanistic studies have provided evidence for a profound immune renewal facilitating the observed beneficial responses.

Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

hematopoietic stem cell

Autologous hematopoietic stem cell transplantation (HSCT) has been recognized as treatment alternative for patients with severe, refractory autoimmune rheumatic diseases (ARDs).

Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort

More hematopoietic stem cell sentences More Sentences

Refractory Autoimmune sentence examples within stem cell transplantation

stem cell transplantation

Autologous haematopoietic stem cell transplantation shows increasing promise as a therapeutic option for patients with treatment-refractory autoimmune disease, particularly systemic sclerosis and multiple sclerosis.

Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases

stem cell transplantation

Autologous haematopoietic stem cell transplantation (HSCT) can be an effective treatment for refractory autoimmune diseases.

Allogeneic HSCT for autoimmune disease: a shared decision

More stem cell transplantation sentences More Sentences

Refractory Autoimmune sentence examples within refractory autoimmune disease

refractory autoimmune disease

Over the past decades, hematopoietic stem cell transplantation (HSCT) has been evolving as specific treatment for patients with severe and refractory autoimmune diseases (ADs), where mechanistic studies have provided evidence for a profound immune renewal facilitating the observed beneficial responses.

Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

refractory autoimmune disease

Therapeutic intensification with autologous peripheral hematopoietic stem cell transplantation (AHSCT) was first used to treat a refractory autoimmune disease in 1994 worldwide [1], and in 1997 in France (registry data).

Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation

More refractory autoimmune disease sentences More Sentences

Learn more from Refractory Autoimmune

Refractory Autoimmune sentence examples within refractory autoimmune hemolytic

refractory autoimmune hemolytic

(2016) Sirolimus for refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review of the treatment of post-transplant autoimmune hemolytic anemia.

Novel findings from the multinational DOVE study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell anaemia

refractory autoimmune hemolytic

We present three patients with refractory autoimmune hemolytic anemia treated with alemtuzumab.

Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab

More refractory autoimmune hemolytic sentences More Sentences

Refractory Autoimmune sentence examples within refractory autoimmune cytopenia

refractory autoimmune cytopenia

Here, we identified three novel SASH3 deleterious variants in four unrelated male patients with a history of combined immunodeficiency and immune dysregulation manifesting as recurrent sinopulmonary, cutaneous and mucosal infections, and refractory autoimmune cytopenias.

SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation.

refractory autoimmune cytopenia

(2015) Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

Incidence and outcomes of rare paediatric non‐hodgkin lymphomas

More refractory autoimmune cytopenia sentences More Sentences

Refractory Autoimmune sentence examples within refractory autoimmune inflammatory

refractory autoimmune inflammatory

Neuromyelitis optica (NMO) is a refractory autoimmune inflammatory disease of the central nervous system without an effective cure.

Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica

refractory autoimmune inflammatory

Rituximab, a monoclonal antibody against CD20 receptor is an important member of the biologic armamentarium for the treatment of various refractory autoimmune inflammatory rheumatic diseases.

Early onset neutropenia and thrombocytopenia following rituximab in lupus nephritis

More refractory autoimmune inflammatory sentences More Sentences

Refractory Autoimmune sentence examples within refractory autoimmune blistering

refractory autoimmune blistering

We conclude by demonstrating that an improved understanding of LPP may not only lead to the development of novel treatment strategies for the disease itself, but may also shed new light on the pathophysiology of more common and treatment-refractory autoimmune blistering diseases.

Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering

refractory autoimmune blistering

The treatment of refractory autoimmune blistering diseases (AIBDs) has always been a challenge.

Treatment Update of Autoimmune Blistering Diseases.

More refractory autoimmune blistering sentences More Sentences

Refractory Autoimmune sentence examples within refractory autoimmune bullou

refractory autoimmune bullou

Therapeutic Apheresis (TA) is increasingly applied as support treatment in dermatological diseases especially in severe and/or refractory autoimmune bullous diseases.

Therapeutic Apheresis and/or Monoclonal Antibodies in Dermatological Diseases

refractory autoimmune bullou

This was a multicenter study of rituximab, a chimeric monoclonal immunoglobulin G antibody directed against CD20, for the treatment of refractory autoimmune bullous diseases (pemphigus and pemphigoid).

Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open‐label, single‐arm, phase 1/2 study on 10 Japanese patients

More refractory autoimmune bullou sentences More Sentences

Refractory Autoimmune sentence examples within refractory autoimmune encephalitis

refractory autoimmune encephalitis

Accordingly, tofacitinib could be a new option for patients with refractory autoimmune encephalitis.

Tofacitinib treatment for refractory autoimmune encephalitis

refractory autoimmune encephalitis

This month’s journal club explores three papers relating to clinical presentation, investigation and treatment options for refractory autoimmune encephalitis.

Autoimmune encephalitis: clinical presentation, investigation and treatment

More refractory autoimmune encephalitis sentences More Sentences

More Refractory Autoimmune sentence examples
10.13188/2373-1044.1000067

Therapeutic Apheresis (TA) is increasingly applied as support treatment in dermatological diseases especially in severe and/or refractory autoimmune bullous diseases.

Therapeutic Apheresis and/or Monoclonal Antibodies in Dermatological Diseases

More Refractory Autoimmune sentence examples
10.2169/internalmedicine.6633-20

There are an increasing number of reports on the safe use of rituximab (RTX), a chimeric anti-CD20 monoclonal antibody, in pregnant women with hematological malignancies or refractory autoimmune diseases.

Successful Pregnancies in a Patient with Childhood-onset Steroid-dependent Nephrotic Syndrome during Rituximab Maintenance Therapy

More Refractory Autoimmune sentence examples
10.19746/j.cnki.issn.1009-2137.2021.05.048

Sirolimus, as an immunosuppressant against of mTOR, induces immune tolerance by adjusting Treg cells, which has application prospect in the treatment of refractory autoimmune cytopenia.

[Advances of Sirolimus in the Treatment of Patients with Autoimmune Cytopenia---Review].

More Refractory Autoimmune sentence examples
10.3389/fimmu.2021.619246

We describe a boy with early-onset severe, refractory autoimmune gastritis and biallelic mutations in the LRBA gene causing a premature STOP-codon who was successfully treated with CTLA4-Ig, abatacept, with long term clinical and endoscopic remission.

Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency

More Refractory Autoimmune sentence examples
10.1111/bjh.17437

Here, we discuss a patient presenting with multiple treatment-refractory autoimmune manifestations (AIMs), which preceded the diagnosis of MDS and culminated in the patient requiring an allogeneic bone marrow transplant (allo-BMT).

Successful use of allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome presenting with autoimmune manifestations

More Refractory Autoimmune sentence examples
10.1111/epi.16848

Accordingly, tofacitinib could be a new option for patients with refractory autoimmune encephalitis.

Tofacitinib treatment for refractory autoimmune encephalitis

More Refractory Autoimmune sentence examples
10.1007/s11481-021-10004-9

The diagnosis of inflammatory neuropathies is often challenging, and while PLEX can be very effective in refractory autoimmune diseases, its ineffectiveness can be confounded by misdiagnosis.

The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review.

More Refractory Autoimmune sentence examples
10.1182/blood.2020008629

Here, we identified three novel SASH3 deleterious variants in four unrelated male patients with a history of combined immunodeficiency and immune dysregulation manifesting as recurrent sinopulmonary, cutaneous and mucosal infections, and refractory autoimmune cytopenias.

SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation.

More Refractory Autoimmune sentence examples
10.1007/s00415-021-10800-6

This month’s journal club explores three papers relating to clinical presentation, investigation and treatment options for refractory autoimmune encephalitis.

Autoimmune encephalitis: clinical presentation, investigation and treatment

More Refractory Autoimmune sentence examples
10.21203/RS.3.RS-376937/V1

This retrospective case series will highlight three cases of children with refractory autoimmune disease whose parents sought out and received MSC therapy as a self-decision without first seeking medical advice from our specialty.

Uncharted waters: Mesenchymal stem cell Treatment for Pediatric Refractory Rheumatic Diseases; A Single Center Case Series

More Refractory Autoimmune sentence examples
10.1097/MD.0000000000015206

Rationale: Cyclosporine A (CsA) is a potent immunosuppressive agent originally used to prevent rejection after organ transplantation but now more frequently used for treatment of refractory autoimmune diseases.

A case report of cyclosporine-induced myopathy with subacute muscular atrophy as initial presentation

More Refractory Autoimmune sentence examples
10.1093/brain/awz207

Inclusion body myositis is a late onset treatment-refractory autoimmune disease of skeletal muscle associated with a blood autoantibody (anti-cN1A), an HLA autoimmune haplotype, and muscle pathology characterized by cytotoxic CD8+ T cell destruction of myofibres.

Highly differentiated cytotoxic T cells in inclusion body myositis.

More Refractory Autoimmune sentence examples
10.3892/ijmm.2019.4056

Neuromyelitis optica (NMO) is a refractory autoimmune inflammatory disease of the central nervous system without an effective cure.

Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica

More Refractory Autoimmune sentence examples
10.1111/bjh.15194

(2015) Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

Incidence and outcomes of rare paediatric non‐hodgkin lymphomas

More Refractory Autoimmune sentence examples
10.1177/1078155217750463

We present three patients with refractory autoimmune hemolytic anemia treated with alemtuzumab.

Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab

More Refractory Autoimmune sentence examples
10.3760/cma.j.issn.0253-2727.2019.02.007

Objective: To evaluate the outcomes of splenectomy in the treatment of relapsed/refractory autoimmune hemolytic anemia (AIHA).

[Outcomes of splenectomy in relapsed/refractory autoimmune hemolytic anemia].

More Refractory Autoimmune sentence examples
10.3389/fimmu.2019.01389

We conclude by demonstrating that an improved understanding of LPP may not only lead to the development of novel treatment strategies for the disease itself, but may also shed new light on the pathophysiology of more common and treatment-refractory autoimmune blistering diseases.

Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering

More Refractory Autoimmune sentence examples
10.3760/CMA.J.ISSN.1674-4756.2019.07.029

Objective To discuss the efficacy of sirolimus in the treatment of refractory autoimmune cytopenias.

Treatment for 6 cases of refractory autoimmune cytopenias by sirolimus and literature review

More Refractory Autoimmune sentence examples
10.1136/annrheumdis-2019-eular.4127

RCI has been shown to be effective in steroid-refractory autoimmune disease.

AB0082 REDUCED STEROIDOGENIC ACTIVITY OF REPOSITORY CORTICOTROPIN INJECTION (RCI) INDUCES A DISTINCT CYTOKINE RESPONSE FOLLOWING T CELL ACTIVATION IN VIVO

More Refractory Autoimmune sentence examples
10.1177/1559325819850984

We urge physicians to consider radon as a standard therapy for refractory autoimmune diseases.

Radon Therapy for Autoimmune Diseases Pemphigus and Diabetes: 2 Case Reports

More Refractory Autoimmune sentence examples
10.24294/TI.V2.I3.1078

In other words, NNS will become a bridge with research on refractory autoimmune diseases.

Antinuclear antibodies in Nakajo-Nishimura syndrome. A bridge with research on refractory autoimmune diseases

More Refractory Autoimmune sentence examples
10.1111/1346-8138.14732

This was a multicenter study of rituximab, a chimeric monoclonal immunoglobulin G antibody directed against CD20, for the treatment of refractory autoimmune bullous diseases (pemphigus and pemphigoid).

Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open‐label, single‐arm, phase 1/2 study on 10 Japanese patients

More Refractory Autoimmune sentence examples
10.1016/j.det.2018.12.003

The treatment of refractory autoimmune blistering diseases (AIBDs) has always been a challenge.

Treatment Update of Autoimmune Blistering Diseases.

More Refractory Autoimmune sentence examples
10.1080/14728222.2019.1656718

Anti-MIF pharmacotherapies could also be steroid-sparing in patients with chronic glucocorticoid dependence or refractory autoimmune disease.

Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus

Keywords related to Refractory

Keywords related to Autoimmune

Refractory Autoimmune
Encyclopedia

What is/are Refractory Autoimmune?

Refractory Autoimmune - Therapeutic Apheresis (TA) is increasingly applied as support treatment in dermatological diseases especially in severe and/or refractory autoimmune bullous diseases. [1] There are an increasing number of reports on the safe use of rituximab (RTX), a chimeric anti-CD20 monoclonal antibody, in pregnant women with hematological malignancies or refractory autoimmune diseases. [2] Sirolimus, as an immunosuppressant against of mTOR, induces immune tolerance by adjusting Treg cells, which has application prospect in the treatment of refractory autoimmune cytopenia. [3] We describe a boy with early-onset severe, refractory autoimmune gastritis and biallelic mutations in the LRBA gene causing a premature STOP-codon who was successfully treated with CTLA4-Ig, abatacept, with long term clinical and endoscopic remission. [4] Here, we discuss a patient presenting with multiple treatment-refractory autoimmune manifestations (AIMs), which preceded the diagnosis of MDS and culminated in the patient requiring an allogeneic bone marrow transplant (allo-BMT). [5] Accordingly, tofacitinib could be a new option for patients with refractory autoimmune encephalitis. [6] The diagnosis of inflammatory neuropathies is often challenging, and while PLEX can be very effective in refractory autoimmune diseases, its ineffectiveness can be confounded by misdiagnosis. [7] Here, we identified three novel SASH3 deleterious variants in four unrelated male patients with a history of combined immunodeficiency and immune dysregulation manifesting as recurrent sinopulmonary, cutaneous and mucosal infections, and refractory autoimmune cytopenias. [8] This month’s journal club explores three papers relating to clinical presentation, investigation and treatment options for refractory autoimmune encephalitis. [9] This retrospective case series will highlight three cases of children with refractory autoimmune disease whose parents sought out and received MSC therapy as a self-decision without first seeking medical advice from our specialty. [10] Rationale: Cyclosporine A (CsA) is a potent immunosuppressive agent originally used to prevent rejection after organ transplantation but now more frequently used for treatment of refractory autoimmune diseases. [11] Inclusion body myositis is a late onset treatment-refractory autoimmune disease of skeletal muscle associated with a blood autoantibody (anti-cN1A), an HLA autoimmune haplotype, and muscle pathology characterized by cytotoxic CD8+ T cell destruction of myofibres. [12] Neuromyelitis optica (NMO) is a refractory autoimmune inflammatory disease of the central nervous system without an effective cure. [13] (2015) Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. [14] We present three patients with refractory autoimmune hemolytic anemia treated with alemtuzumab. [15] Objective: To evaluate the outcomes of splenectomy in the treatment of relapsed/refractory autoimmune hemolytic anemia (AIHA). [16] We conclude by demonstrating that an improved understanding of LPP may not only lead to the development of novel treatment strategies for the disease itself, but may also shed new light on the pathophysiology of more common and treatment-refractory autoimmune blistering diseases. [17] Objective To discuss the efficacy of sirolimus in the treatment of refractory autoimmune cytopenias. [18] RCI has been shown to be effective in steroid-refractory autoimmune disease. [19] We urge physicians to consider radon as a standard therapy for refractory autoimmune diseases. [20] In other words, NNS will become a bridge with research on refractory autoimmune diseases. [21] This was a multicenter study of rituximab, a chimeric monoclonal immunoglobulin G antibody directed against CD20, for the treatment of refractory autoimmune bullous diseases (pemphigus and pemphigoid). [22] The treatment of refractory autoimmune blistering diseases (AIBDs) has always been a challenge. [23] Anti-MIF pharmacotherapies could also be steroid-sparing in patients with chronic glucocorticoid dependence or refractory autoimmune disease. [24]

hematopoietic stem cell

Over the past decades, hematopoietic stem cell transplantation (HSCT) has been evolving as specific treatment for patients with severe and refractory autoimmune diseases (ADs), where mechanistic studies have provided evidence for a profound immune renewal facilitating the observed beneficial responses. [1] Autologous hematopoietic stem cell transplantation (HSCT) has been recognized as treatment alternative for patients with severe, refractory autoimmune rheumatic diseases (ARDs). [2] Therapeutic intensification with autologous peripheral hematopoietic stem cell transplantation (AHSCT) was first used to treat a refractory autoimmune disease in 1994 worldwide [1], and in 1997 in France (registry data). [3] (2016) Sirolimus for refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review of the treatment of post-transplant autoimmune hemolytic anemia. [4]

stem cell transplantation

Autologous haematopoietic stem cell transplantation shows increasing promise as a therapeutic option for patients with treatment-refractory autoimmune disease, particularly systemic sclerosis and multiple sclerosis. [1] Autologous haematopoietic stem cell transplantation (HSCT) can be an effective treatment for refractory autoimmune diseases. [2]

refractory autoimmune disease

Over the past decades, hematopoietic stem cell transplantation (HSCT) has been evolving as specific treatment for patients with severe and refractory autoimmune diseases (ADs), where mechanistic studies have provided evidence for a profound immune renewal facilitating the observed beneficial responses. [1] Therapeutic intensification with autologous peripheral hematopoietic stem cell transplantation (AHSCT) was first used to treat a refractory autoimmune disease in 1994 worldwide [1], and in 1997 in France (registry data). [2] There are an increasing number of reports on the safe use of rituximab (RTX), a chimeric anti-CD20 monoclonal antibody, in pregnant women with hematological malignancies or refractory autoimmune diseases. [3] This retrospective case series will highlight three cases of pediatric refractory autoimmune disease whose parents sought out and received MSC therapy as a self-decision without first seeking medical advice from our specialty. [4] The diagnosis of inflammatory neuropathies is often challenging, and while PLEX can be very effective in refractory autoimmune diseases, its ineffectiveness can be confounded by misdiagnosis. [5] This retrospective case series will highlight three cases of children with refractory autoimmune disease whose parents sought out and received MSC therapy as a self-decision without first seeking medical advice from our specialty. [6] Rationale: Cyclosporine A (CsA) is a potent immunosuppressive agent originally used to prevent rejection after organ transplantation but now more frequently used for treatment of refractory autoimmune diseases. [7] Inclusion body myositis is a late onset treatment-refractory autoimmune disease of skeletal muscle associated with a blood autoantibody (anti-cN1A), an HLA autoimmune haplotype, and muscle pathology characterized by cytotoxic CD8+ T cell destruction of myofibres. [8] Autologous haematopoietic stem cell transplantation shows increasing promise as a therapeutic option for patients with treatment-refractory autoimmune disease, particularly systemic sclerosis and multiple sclerosis. [9] Autologous haematopoietic stem cell transplantation (HSCT) can be an effective treatment for refractory autoimmune diseases. [10] TCZ use will probably be more common in the future to treat refractory autoimmune diseases. [11] RCI has been shown to be effective in steroid-refractory autoimmune disease. [12] We urge physicians to consider radon as a standard therapy for refractory autoimmune diseases. [13] In other words, NNS will become a bridge with research on refractory autoimmune diseases. [14] Anti-MIF pharmacotherapies could also be steroid-sparing in patients with chronic glucocorticoid dependence or refractory autoimmune disease. [15]

refractory autoimmune hemolytic

(2016) Sirolimus for refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review of the treatment of post-transplant autoimmune hemolytic anemia. [1] We present three patients with refractory autoimmune hemolytic anemia treated with alemtuzumab. [2] Objective: To evaluate the outcomes of splenectomy in the treatment of relapsed/refractory autoimmune hemolytic anemia (AIHA). [3]

refractory autoimmune cytopenia

Here, we identified three novel SASH3 deleterious variants in four unrelated male patients with a history of combined immunodeficiency and immune dysregulation manifesting as recurrent sinopulmonary, cutaneous and mucosal infections, and refractory autoimmune cytopenias. [1] (2015) Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. [2] Objective To discuss the efficacy of sirolimus in the treatment of refractory autoimmune cytopenias. [3]

refractory autoimmune inflammatory

Neuromyelitis optica (NMO) is a refractory autoimmune inflammatory disease of the central nervous system without an effective cure. [1] Rituximab, a monoclonal antibody against CD20 receptor is an important member of the biologic armamentarium for the treatment of various refractory autoimmune inflammatory rheumatic diseases. [2]

refractory autoimmune blistering

We conclude by demonstrating that an improved understanding of LPP may not only lead to the development of novel treatment strategies for the disease itself, but may also shed new light on the pathophysiology of more common and treatment-refractory autoimmune blistering diseases. [1] The treatment of refractory autoimmune blistering diseases (AIBDs) has always been a challenge. [2]

refractory autoimmune bullou

Therapeutic Apheresis (TA) is increasingly applied as support treatment in dermatological diseases especially in severe and/or refractory autoimmune bullous diseases. [1] This was a multicenter study of rituximab, a chimeric monoclonal immunoglobulin G antibody directed against CD20, for the treatment of refractory autoimmune bullous diseases (pemphigus and pemphigoid). [2]

refractory autoimmune encephalitis

Accordingly, tofacitinib could be a new option for patients with refractory autoimmune encephalitis. [1] This month’s journal club explores three papers relating to clinical presentation, investigation and treatment options for refractory autoimmune encephalitis. [2]